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This work is aimed to evaluate a method to detect the residual magnetic nanoparticles (MNPs) in animal tissues.
Ferric ions released from MNPs through acidification with hydrochloric acid can be measured by complexation with
potassium thiocyanate. MNPs in saline could be well detected by this chemical colorimetric method, whereas the
detected sensitivity decreased significantly when MNPs were mixed with mouse tissue homogenates. In order to
check the MNPs in animal tissues accurately, three improvements have been made. Firstly, proteinase K was used to
digest the proteins that might bind with iron, and secondly, ferrosoferric oxide (Fe3O4) was collected by a magnetic
field which could capture MNPs and leave the bio-iron in the supernatant. Finally, the collected MNPs were
carbonized in the muffle furnace at 420°C before acidification to ruin the groups that might bind with ferric ions
such as porphyrin. Using this method, MNPs in animal tissues could be well measured while avoiding the
disturbance of endogenous iron and iron-binding groups.
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Nanotechnology is widely used in drug or gene delivery
and targeted therapy [1-4]. The importance of targeted
drug delivery is to transport a drug directly to the center
of the disease under various conditions and thereby treat
it separately, with less effect on other tissues. The nano-
particle designed for drug delivery should be biodegrad-
able and biocompatible [5,6]. Due to its good
biodegradability and biocompatibility, the engineered
magnetic nanoparticles (MNPs) could be well used in
disease diagnosis and even in drug delivery and targeted
therapy [7-14]. They can be simultaneously functiona-
lized and guided by a magnetic field [15-17]. The safety
of designed MNPs depends on the safety of linked mole-
cules and the magnetic cores. So, evaluating how MNPs
distribute and metabolize in different tissues of animals
is very important. Moreover, this information is capital
to give reference of its optimal dosage and administra-
tion route. Magnetic resonance imaging, Prussian blue
staining, and transmission electron microscopy were* Correspondence: wangyuxia1962@hotmail.com
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in any medium, provided the original work is pused to detect the distribution of the magnetic nanopar-
ticles in vivo. As a vector, MNPs often bond with some
conjugate such as cisplatin, and the distribution of con-
jugates had been used to indicate MNP distribution [18].
Determining iron ions using inductively coupled plasma-
mass spectrometry (ICP-MS) is a very sensitive method
and has been used to determine the concentration of
MNPs in animal tissues [19]. This method could meas-
ure the total endogenous and exogenous iron in different
tissues of animals. When the tissue contains high con-
centration of iron ions, the MNP concentration could
not be calculated by using this method. Yin et al. have
explored the toxicity of Fe3O4 coated with glutamic acid
labeled with Fe59 and determined their distribution in
mice. Separating from endogenous iron labeled with
Fe59 could directly catch the trace of MNPs in the differ-
ent tissues of mice, including the absorption, distribution
and clearance, and accumulation in tissues and the prob-
able target organ, and evaluate its pharmacokinetic pro-
file in vivo [20]. However, with the same disadvantage of
ICP mass, labeled Fe59 could not give the information
on whether it is a degraded iron ion or an atom in
MNPs. Therefore, we try to establish a method topen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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olism feature of MNPs in animal tissues.
Experimental materials and methods
Animals
CD-1 strain mice were supplied by Vital River Labora-
tory Animal Technology Co. Ltd. (SCXK(Jing)2006-
2009, Beijing, China). They were housed in a controlled
environment (21 ± 2°C, 55 ± 5% of humidity, 12-h dark/
light cycle with light provided between 6 am and 6 pm).
Food and water were given ad libitum. All the animal
experiments were carried out in the Beijing Center for
Drug Safety Evaluation, in accordance with a protocol
approved by the Institutional Animal Care and Use
Committee of the Center, which is in compliance with
the guidelines of the Association for Assessment and
Accreditation of Laboratory Animal Care International.
Materials
The MNPs were from Shanghai Jiaotong Unversity. Iron
chloride hexahydrate was from Sinopharm Chemical Re-
agent Co. Ltd. (Shanghai, China). The MNPs were
coated with cetyltrimethyl ammonium bromide at the
size of 25 to 35 nm. Magnetic field (MagneSphere Tech-
nology Magnetic Separation Stands, Z5341) was from
Promega (Madison, WI, USA). Muffle furnace (SX-8-10)
was from Tianjin Taisite Instrument Co. Ltd. (Tianjin
City, China).
Establishing a method to determine ferric ions in vitro
For quantitive analysis of MNPs the concentration of
iron ion was created as a standard for MNPs. Ferric
chloride was use to analyze the iron content. Potassium
thiocyanide colorimetry showed a good linear relation-
ship and was used to determine ferric ions in MNPs
treated with hydrochloride acid at 100°C. Different con-
centration of 0.5 ml ferric chloride was mixed with an
equal volume of 2N hydrochloride acid and boiled for 10
min. The acidified solution was cooled to room
temperature and added 120 μl of 5M potassium thiocya-
nide. Ninety-six-well plates were used in this detection
method. The colored reaction product (150 μl/well) was
measured at 480 nm on a spectral scanning multimode
reader (Varioskan Flash version 2.4.3, Thermo Scientific,
Logan, UT, USA). The sonicated and acidified MNPs
could be treated in the same way and its ferric ions con-
centration could be calculated by the ferric chloride
standard curve.
The influence of animal tissue on the determination of
ferric ions in MNPs
For the assessment of MNPs in different tissues by
colorimetry, the normal mice were narcotized with
ether. The whole blood was collected into heparin-coated tube and diluted with nine volumes of saline
before mixing with MNPs. Different tissues were har-
vested. Tissues from three mice were mixed and
homogenized in ten volumes of ice-cold saline in a
homogenizer (ULTRA-TURRAX T25, IKA-Labortech-
nik, Staufen, Germany) for 10 s. Three hundred micro-
liters of MNPs at 0.078 to 40 μg/ml in saline was
mixed with an equal volume of tissue homogenate and
acidified with 80 μl of 6N hydrochloric acid. The acid-
ified solution was centrifuged at 14,000 rpm for 6 min,
and then, the supernatants were colorized with 80 μl
of 5M potassium thiocyanide.
The iron background in mouse tissues
One hundred microliters of 10% mouse tissue homogen-
ate was mixed with 500 μl of saline and then treated with
proteinase K at the final concentration of 100 μg/ml
under 55°C to 65°C for 0.5 h. The samples were then
transferred into crucibles, oven dried on a hot plate, and
then carbonized in a muffle at 420°C for 2 h. Cooled to
room temperature, the samples were acidified with 0.5 ml
1N hydrochloric acid at 100°C for 10 min. Cooled to
room temperature, 1N hydrochloric acid was replenished
to the final volume of 1.0 ml. Centrifuged at 10,000 rpm
for 10 min, 0.5 ml of the supernatants was colorized with
60 μl of 5M potassium thiocyanide. The concentration of
ferric ions was calculated referencing the result from ferric
chloride standard.
The determination of MNPs in blood treated with
proteinase K with/without magnetic field collection
MNPs at different concentrations in 300 μl of saline
were mixed with 30 or 300 μl of mouse whole blood and
replenished with saline to the final volume of 600 μl.
Aliquots were treated with/without 3 μl of proteinase
K, 20 mg/ml, to the final concentration of 100 μg/ml
under 55°C to 65°C for 0.5h and centrifuged at 14,000
rpm for 5 min. The 200 μl of the supernatant was
mixed with 400 μl of saline to check whether Fe3O4
remained after centrifugation. The precipitate was
washed with 0.6 ml saline, centrifuged two times and
suspended in 600 μl of saline. Each sample was added
with 80 μl 6N hydrochloric acid and boiled for 10 min.
After cooling in a water bath at room temperature, the
solutions were colorized with 80 μl 5M KSCN, and their
A480 were measured.
Using magnetic field to separate MNPs from the
endogenous iron followed by carbonation to ruin ferric
ions binding groups
Being a standard, 300 μl of MNPs at 40 μg/ml in saline
was diluted with 200 μl of saline, acidified with 500 μl
2N hydrochloric acid, and colorized with 120 μl 5M
KSCN. The same aliquots of MNPs, 300 μl in saline,
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of saline containing 50% mouse blood. The crucibles
containing these solutions were put on a magnetic field,
and the MNPs were collected and washed two times
with saline. The precipitates could be directly acidified
with 1 ml 1N hydrochloric acid or carbonized in a
muffle furnace at 420°C for 2 h, cooled to room
temperature, and then be acidified. After acidification
at 100°C for 10 min and cooling to room temperature,
all the samples above were replenished and colorized
with 120 μl 5M KSCN. Using the same procedure,
MNPs mixed in the mouse tissue homogenate was
collected and determined. The collected ratio was cal-
culated and compared with the result of the MNPs in
saline.Determination of MNPs in the blood of mice treated with
MNPs by intravenous injection
CD-1 mice were i.v.-administrated with MNPs at a dose
of 7.5 mg/kg. At different time points after MNP treat-
ment, the whole blood was collected in heparin-coated
tube. In a crucible, 0.1 ml of whole blood was mixed
with 0.9 ml of saline, and MNPs were collected and
washed two times with saline accompanied with mag-
netic field separation. The collected precipitates were
carbonized as before. The residues were suspended in
0.5 ml 1N hydrochloric acid and colorized with 60 μl
5M KSCN. The concentration of ferric ions was calcu-
lated, referencing with ferric chloride standard with at-




















Figure 1 Standard curve of ferric ions determination. Different concen
value of absorbance at 480 nm was detected. The concentration scale is 0
presented as means ± standard deviations.Results
The standard of ferric ions determination in vitro
Samples containing different concentrations of ferric
ions in water were prepared by diluting the iron chloride
solution and acidifying and colorizing following the
method described above. The formula was obtained after
logistic regression (Figure 1). This examination was
repeated three times within the day or within 3 days to
calculate the relative standard deviation (RSD) respect-
ively. The RSDs at different concentrations of iron
within 1 day or within 3 days were lower than 6%
(Table 1).
The magnetic nanoparticle sample was diluted accord-
ing to the ferric ions concentration and acidified and
colorized in the same way to measure ferric ions in iron
chloride. The values of absorbance at 480 nm of the col-
orized solution loaded onto the same 96-well plate were
determined. The result indicated that this method could
be used well to measure the iron concentration and fur-
ther represent the MNP concentration (Figure 2).
The influence of blood content on the measure of MNPs
In order to elucidate whether the tissue content could
disturb the measurement of ferric ions from MNPs, the
MNP final concentration at 40 μg/ml of MNP was pre-
pared using saline containing 5% or 50% mouse whole
blood. MNP in saline containing 5% or 50% blood was
treated with/without proteinase K under 55°C to 65°C
and centrifuged. The supernatant and washed precipitate
were acidified and colorized respectively. The A480
results indicated that different treatments affected the Fe100 125 150 175 200 225
n of Fe3+ (mg/L)
Model Logistic
Equation








A1 0. 04882 0. 0029
A2 10. 79326 1. 13168
x0 165. 01972 29. 50931
75040.014571.1p
trations of ferric ions were colorized with potassium thiocyanate. The
to 200 mg/L. Each assay was performed in triplicates. Data are
Table 1 The relative standard deviation in the
determination of ferric ions (%)
Ferric ions
(mg/L)




Mean SD Mean SD
0 0.0458 0.0027 5.93 0.0462 0.0025 5.32
0.31 0.0540 0.0008 1.48 0.0554 1.90 × 10−3 3.43
0.62 0.0665 0.0031 4.68 0.0682 0.0038 5.58
1.25 0.0878 0.0013 1.47 0.0894 2.00 × 10−3 2.25
2.5 0.1301 0.0029 2.23 0.1329 0.004 2.97
5 0.2187 0.0049 2.25 0.2253 0.0093 4.13
10 0.4111 0.0084 2.03 0.4219 0.0127 3.02
20 0.8206 0.0297 3.61 0.846 0.0343 4.05
40 1.6834 0.027 1.60 1.6896 0.0202 1.20
80 3.442 0.0633 1.84 3.4985 0.0851 2.43
100 4.2956 0.0671 1.56 4.3911 0.1499 3.41
200 5.9739 0.036 0.60 5.9739 0.036 0.60
The RSD at different concentrations of ferric ions was the relative percentage
of the standard deviation with mean value calculated from three
determinations of ferric ions in 1 day or 3 days, respectively.
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decreased significantly, and this decrease could not be
alleviated by treating with proteinase K which could di-
gest the protein that might combine with Fe3O4 or Fe
3+
(Figure 3). These results reminded that there were some
organic components in mouse blood that could catch
iron, and these components could be released suffi-















Figure 2 The determination of iron in magnetic nanoparticles and fer
magnetic nanoparticles and ferric chloride were colorized with potassium t
presented as means ± standard deviations.Ferric ion determination after separating from
endogenous iron and ruining ferric ion binding groups
The determination of ferric ions in blood indicated that
different treatments affected Fe determination. Even
with 5% of whole blood, the A480 decreased signifi-
cantly, and this decrease could not be alleviated by treat-
ing with proteinase K which could digest the protein
that might combine with Fe3O4 or Fe
3+. These results
reminded that there were some organic components in
mouse blood that could catch iron, and these compo-
nents could be released sufficiently after proteinase K
treatment. Carbonation is one of the methods that could
effectively ruin the groups that might bind with iron
from MNPs which were separated from endogenous iron
existing in the blood under a magnetic field.
The same aliquots of MNPs in saline containing 50%
mouse blood were added into crucibles on a magnetic
field to collect MNPs and washed two times with sa-
line. The precipitates that were uncarbonized or carbo-
nized in a muffle furnace were acidified and colorized.
Compared with the saline standard control, almost
90% of MNPs could be recycled by the magnetic field.
When MNPs in saline containing 20% of mouse blood
were magnetically recycled and uncarbonized, only half
of the ferric ions signal compared with that in saline
control was given. Adding proteinase K did not allevi-
ate this decrease. Fortunately, after being digested with
proteinase K, collected on a magnetic field, and carbo-
nated in a muffle, the ferric ions signal could almost
match the same level of MNPs in the saline control








ric chloride. Different concentrations of ferric ions produced from
hiocyanate. Each assay was performed in quadruplicates. Data are
















Concentration of Fe3O4(mg/L) 
 saline
 Blood 30 µl
 Blood 30 µl+Proteinanse K
 Blood 300 µl+Proteinanse K 
 Supernatant of Blood 30 µl+Proteinanse K
 Supernatant of Blood 300 µl+Proteinanse K
Figure 3 The ferric ions signal of MNPs in the mouse blood sample. The influence of blood content on MNP determination was measured
by mixed mouse blood and MNPs. Proteinase K used to digest the blood proteins might bind with MNPs or ferric ions. Each assay was
performed in triplicates. Data are presented as means ± standard deviations.
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mouse tissues might disturb the MNP determination,
the 10% mouse tissue homogenate in saline was pre-
pared. One hundred microliters of tissue homogenate
was mixed with 500 μl of saline. After the digestion with
proteinase K, carbonation in a muffle, and acidification






















Saline saline blood s
Figure 4 Determination of MNPs in mouse blood samples by differen
containing 20% of mouse blood was measured respectively. Each assay wa
deviations.and calculated referencing to the standard as mentioned
before. The results showed that endogenous iron con-
tents were significantly different depending on the kind
of tissue. Some tissues such as blood, spleen, and liver
have a high concentration of iron, indicating that it is
important to separate endogenous iron in MNP detec-




t treatments. The same amount of MNPs in saline or saline
s performed in triplicates. Data are presented as means ± standard



















Figure 5 Endogenous iron in different mouse tissues. Iron concentrations in mouse blood, liver, kidney, lung, spleen, and intestine were
measured. Each assay was performed in triplicates. Data are presented as means ± standard deviations.
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http://www.nanoscalereslett.com/content/7/1/665concentration is low, the magnetic collection and car-
bonation of MNPs are still important because the groups
which might bind with ferric ions should be cleared be-
fore colorization. Using the same method, the MNPs
mixed in different homogenates of mouse tissue were
collected under magnetic field after proteinase K diges-
tion and carbonated followed by acidification and color-
ization. The ratio of ferric ions concentration in




















Figure 6 Determination of MNPs mixed in different mouse tissues. M
determined, comparing with the result of MNPs in saline. Each assay was p
deviations.The result showed that more than 80% of MNPs could
be measured without endogenous iron disturbance
(Figure 6).
Discussion
Because nanoparticles (NPs) have the unique physical
and chemical properties compared with general sub-
stance, their safety could not be well evaluated by nor-
mal evaluation methods only. Apart from the toxicity oflungs spleen intestine
issue
NPs were separated from endogenous iron by magnetic field and
erformed in triplicates. Data are presented as means ± standard
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with the administration way and the distribution path in
the animal. Magnetic nanoparticles (MNPs) are drawing
increasingly attention due to its unique purposes such as
disease diagnosis and drug delivery. Though MNPs
could be concentrated at the desired site lead by an ex-
ternal magnet [21] and have been thought to be bio-
degradable and biocompatible [22], the toxicity of iron
in animals should not be ignored because overload of
iron oxide has potential toxicity to blood, liver, spleen
and kidneys [19,23], especially when the iron was in
nanoscale. The limited studies on MNPs toxicity were
pointed at the influence of MNP construction, size, sur-
face chemistry and the design of their administration in
the toxic outcomes as anticipated [24]. Establishing an
experimental method to detect the concentration of
MNPs in different tissue and organ of animals is very
important to obtain the rule of MNPs distribution and
metabolism and then to suspect the potential toxicity.
In this study, chemical colorimetric method to deter-
mine the residual MNPs in the tissues of mice has been
established. Whole blood was selected as the tissue to
establish the MNPs determination method because of
the blood half-life is a capital value indicating whether
MNPs could evade uptake by RES [25-28]. Compared
with other tissues, MNPs in blood was relatively difficult
to be measured because the red blood cells contain large
amounts of iron. Some research reported that the MNPs
in the plasma could be separated with blood cell by cen-
trifugation [29]. It is possible that the MNPs could ag-
gregate and co-precipitate with blood cells. In this
research the iron backgrounds in different tissues of
mouse were determined elucidating the high bio-iron
background in whole blood, spleen, liver and even in in-
testine. Using ICP mass MNPs, signals in these samples
could not be detected accurately especially when lower
dose of MNPs was used. So using a magnet to separate
MNPs from bio-iron is very important. Ultrasound was
used to avoid the aggregation of MNPs and to break the
blood cells preventing their precipitation on magnetic
field. Proteinase K is effective enzyme to digest proteins
might bind with MNPs. Carbonation in muffle and then
acidification could oxidize ferrous ions to ferric ions
which would be colorized by KSCN. The groups that
might complex with ferric ions in tissues could be
destroyed when the sample was carbonated. This
method will be used to measure the MNPs distribution
and metabolism in mice in our further research, espe-
cially to validate whether this method could be used to
check the MNPs coupled with antibody or other medi-
cine groups.
In this study, we established a method to determine
MNPs in mouse tissues without the disturbance of en-
dogenous iron. Even being little tedious, the method issafe and effective. Following more and more uses of
MNPs in vivo take place, this method could be of great
assistance in measurements of MNPs itself and MNPs
coupled with drug or antibody, especially when the tis-
sue containing high level iron and the animal treated
with lower dose of MNPs.
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